Clinical data indicate that a positive aPL profile correlates with more extensive organ involvement and higher risk of thrombotic and non-thrombotic manifestations in patients with SLE [42, 48, 49], in line with our findings. This evidence concerns the gene FASLG and systemic lupus erythematosus.